logo-loader
viewBraingrid Ltd.

Braingrid unit teams up with Scanit Technologies to support cannabis growers

The subsidiary will integrate its technology and cloud platform with Scanit's on-premises systems to provide metrics for airborne disease detection

A marijuana plant
Disease is a key concern for cannabis growers, according to Braingrid

Braingrid Ltd (CSE:BGRD) (OTCMKTS:BGRDF) announced Tuesday that its subsidiary has entered into an integration agreement with Scanit Technologies Inc to support cannabis growers.

Under their three-year agreement, Braingrid Corp will integrate its Sentroller technology and cloud platform with Scanit's on-premises systems to provide metrics for airborne disease detection, along with Braingrid's wireless, environmental, monitoring technology.

The agreement allows Braingrid and Scanit to each provide their analytics on one screen to make a grower's job easier and take swift action to avoid disease outbreaks.

READ: Braingrid unveils strategic tie-up with A&L Canada Laboratories

Toronto-based Braingrid added that the companies will explore different business combinations, including a role for Braingrid as a value-added reseller. No terms have yet been determined, according to Braingrid.

Scanit, located in Fremont, California, has developed equipment and software to provide in near real-time, early airborne disease detection for outdoor and indoor growers. This solution detects, measures and identifies airborne diseases that are causing yield losses and crop failures before they are visible.

Disease, especially powdery mildew and botrytis, is a key concern for most cannabis growers and cost the industry millions of dollars in lost product, according to Braingrid.

"Growers who use Scanit and Braingrid solutions will be at the leading edge of early disease detection,” Braingrid CEO Michael Kadonoff said in a statement.

‘Meaningful insights’

Scanit CEO Pete Manautou added that “the critical data from both our systems will produce meaningful insights to our grower customers, enabling them to optimize yields and operational costs.”

Shares of Braingrid traded at C$0.18 in Monday’s Canadian trading. They fetched US$0.14 on the OTC Markets.

Last month, the company announced that it had struck up a partnership with A&L Canada Laboratories.

Under the terms of their three-year deal, Braingrid will serve as the mobile field lab supplier of real-time data to clients of A&L, an agricultural testing lab with a focus on cannabis.

Contact Dennis Fitzgerald at [email protected]

Quick facts: Braingrid Ltd.

Price: 0.005 CAD

CSE:BGRD
Market: CSE
Market Cap: $249.59 k
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Braingrid Ltd. named herein, including the promotion by the Company of Braingrid Ltd. in any Content on the Site, the Company receives from...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Braingrid Corporation secures 5.1 million dollars in financing over 3 years

Braingrid Corporation (CSE:BGRD) CEO Michael Kadonoff joined Steve Darling from Proactive Investors in Toronto to talk about their agreement with the European High Growth Opportunities Securitization Fund for 5.1 million dollars. Kadonoff told Proactive how the financing will work and...

on 06/12/2019

2 min read